UA97076C2 - Anti-inflammatory ointment based on sulfanilamide - Google Patents
Anti-inflammatory ointment based on sulfanilamideInfo
- Publication number
- UA97076C2 UA97076C2 UAA201105168A UAA201105168A UA97076C2 UA 97076 C2 UA97076 C2 UA 97076C2 UA A201105168 A UAA201105168 A UA A201105168A UA A201105168 A UAA201105168 A UA A201105168A UA 97076 C2 UA97076 C2 UA 97076C2
- Authority
- UA
- Ukraine
- Prior art keywords
- sulfanilamide
- inflammatory
- ointment based
- inflammatory ointment
- ointment
- Prior art date
Links
- 239000002674 ointment Substances 0.000 title abstract 3
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 title abstract 3
- 229940124530 sulfonamide Drugs 0.000 title abstract 3
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 2
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 abstract 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- DSSYKIVIOFKYAU-UHFFFAOYSA-N camphor Chemical compound C1CC2(C)C(=O)CC1C2(C)C DSSYKIVIOFKYAU-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 235000015277 pork Nutrition 0.000 abstract 1
- 230000001172 regenerating effect Effects 0.000 abstract 1
- 229940099259 vaseline Drugs 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to pharmacy and medicine, in particular to pharmaceutical compositions in ointment form having anti-inflammatory, analgetic, antimicrobial, wound-healthing and regenerative action. The ointment contains sulfanilamide, racemic camphor, Vaseline, rendered pork fat, butylhydroxyanisol and butylhydroxytoluene. Sulfanilamide is in micronized state.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201105168A UA97076C2 (en) | 2011-04-22 | 2011-04-22 | Anti-inflammatory ointment based on sulfanilamide |
| RU2012107600/15A RU2493837C1 (en) | 2011-04-22 | 2012-02-28 | Anti-inflammatory ointment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA201105168A UA97076C2 (en) | 2011-04-22 | 2011-04-22 | Anti-inflammatory ointment based on sulfanilamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA97076C2 true UA97076C2 (en) | 2011-12-26 |
Family
ID=49164508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201105168A UA97076C2 (en) | 2011-04-22 | 2011-04-22 | Anti-inflammatory ointment based on sulfanilamide |
Country Status (2)
| Country | Link |
|---|---|
| RU (1) | RU2493837C1 (en) |
| UA (1) | UA97076C2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1009789B (en) * | 2019-03-18 | 2020-08-03 | Ελενη Δημητριου Πατσιανιδη | Ointment for burns |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA83402C2 (en) * | 2006-07-06 | 2008-07-10 | Светлана Владимировна Бабий | Anti-inflammatory analgesic ointment |
| RU2401104C2 (en) * | 2008-12-04 | 2010-10-10 | Закрытое акционерное общество "Биологические исследования и системы" | Topical and external tilorone pharmaceutical composition for treatment of purulent-destructive mucosal and skin diseases, systemic diseases in immunodeficiency states |
-
2011
- 2011-04-22 UA UAA201105168A patent/UA97076C2/en unknown
-
2012
- 2012-02-28 RU RU2012107600/15A patent/RU2493837C1/en active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2012107600A (en) | 2013-09-10 |
| RU2493837C1 (en) | 2013-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015008628A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
| EA201690102A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYLFUMATE FOR INTRODUCTION TO LOW DAILY DOSE | |
| MX2015008627A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
| MY188960A (en) | Cyclic boronic acid ester derivatives and therapeutic uses thereof | |
| WO2012112410A3 (en) | Micronized placental tissue compositions and methods for making and using the same | |
| UA109661C2 (en) | PHARMACEUTICAL COMPOSITION OF TRAMADOL AND COXYBY CO-CRYSTALS | |
| BR112015000229A2 (en) | stable aqueous formulations of etanercept | |
| EP3626253A3 (en) | Stable formulations of linaclotide | |
| BR112015011430A2 (en) | composition for immediate and prolonged release | |
| MX2013003635A (en) | N-heteroaryl compounds. | |
| BR112013008601A8 (en) | CLEVIDIPINE EMULSION FORMULATIONS CONTAINING ANTIMICROBIAL AGENTS | |
| PH12013500007A1 (en) | Piperidine derivatives and their use for the treatment of metabolic disorders | |
| BRPI0806713A8 (en) | STABLE THIACUMICIN COMPOSITIONS | |
| EP3878445A3 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
| MY168212A (en) | A new therapeutical composition containing apomorphine as active ingredient | |
| MY157673A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
| MX344846B (en) | COMBINATION OF ACTIVE LOADED GRANULES WITH ADDITIONAL ASSETS. | |
| GB2523707A (en) | Novel pharmaceutical formulations and their use in the treatment of periodontal disease | |
| WO2015001163A3 (en) | Lipid nanoparticles for healing wounds | |
| IN2015DN01328A (en) | ||
| MX2014014579A (en) | O/w-emulsion-type topical pharmaceutical compositions containing a retinoid. | |
| MX364652B (en) | Pharmaceutical formulation comprising ciclesonide. | |
| WO2015002755A3 (en) | Compounds for the treatment of malaria | |
| EP2682129A3 (en) | Compositions Comprising Muscarinic Receptor Antagonist and Glucose Anhydrous | |
| AU2012345659A8 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same |